Clinical Trial Update: Thalidomide-Dexamethasone for Multiple Myeloma [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update of thalidomide-dexamethasone for multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Thalidomide-Dexamethasone

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Multiple Myeloma | Phase 2, Phase 3 | Status: COMPLETED